Cite
MLA Citation
Ravi Shankar P. Singh et al.. “Innovative Randomized Phase I Study and Dosing Regimen Selection to Accelerate and Inform Pivotal COVID‐19 Trial of Nirmatrelvir.” Clinical pharmacology & therapeutics, vol. 112, no. 1, 2022, pp. 101–111. http://access.bl.uk/ark:/81055/vdc_100158005177.0x00005f